openPR Logo
Press release

Acquired Orphan Blood Diseases Therapeutics Market to Boom; Increasing Prevalence of Blood Disorders to Bolster Industry Growth: Fortune Business Insights™

08-30-2021 12:34 PM CET | Health & Medicine

Press release from: Fortune Business Insights

Acquired Orphan Blood Diseases Therapeutics

Acquired Orphan Blood Diseases Therapeutics

Market Overview

The global acquired orphan blood diseases therapeutics market size is expected to grow exponentially because of the rising cases of blood disorders among the population. The increasing awareness regarding blood disorders is expected to boost market growth. Fortune Business Insights™ mentions this information in its report, titled, "Acquired Orphan Blood Diseases Therapeutics Market, 2021-2028."

Acquired orphan blood diseases therapeutics are a therapy used to cure rare blood diseases, wherein the lack of red blood cells negatively affects the health of the person suffering from the disease. It is used to cure diseases, such as myelodysplastic syndrome, paroxysmal nocturnal hemoglobinuria (PNH), and acquired agranulocytosis. Further, the rising awareness among the population regarding blood disorders is expected to increase the demand for advanced therapies. The rising investment in healthcare sectors can enhance the demand for acquired orphan blood diseases therapeutics. Thus, these factors can enhance the market growth during the foreseeable period.

Request a Sample Copy of the Research Report

Impact of COVID-19

Rising Demand from Healthcare Sector to Boost Market Growth

This market is expected to be positively impacted during the COVID-19 pandemic due to the rising demand for advanced blood therapies, such as acquired orphan blood diseases therapeutics from the healthcare sector. The rising cases of blood disorders can lead to the adoption of advanced treatment procedures. The demand for advanced medical equipment and procedures such as acquired orphan blood diseases therapeutics is increasing during the pandemic, which, in turn, enhances production activities. Manufacturers are operating at reduced capacities and implementing safety procedures to avoid the spread of the virus. Therefore, these factors can enhance the market growth during the pandemic.

To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/acquired-orphan-blood-diseases-therapeutics-market-102010

Segments

By therapy, the market is segregated into thrombopoietin receptor agonists, activated prothrombin complex concentrate, immunoglobulin infusion therapy, recombinant factor, and others. As per disease, it is divided into myelodysplastic syndrome, paroxysmal nocturnal hemoglobinuria (PNH), acquired von willebrand syndrome, acquired hemophilia, acquired agranulocytosis, and others. Based on distribution channels, it is categorized intoretail pharmacy, hospital pharmacy, and others. Geographically, it is clubbed into Europe, North America, Latin America, Asia Pacific, and the Middle East & Africa.

Highlights of the Report

The report highlights the latest market trends and the leading segments.
It conducts a comprehensive analysis of the impact of COVID-19 and the driving and restraining factors.
This report examines the regional development and the strategies deployed by the prominent companies operating in the market.
Quick Buy Acquired Orphan Blood Diseases Therapeutics

Drivers and Restraints

Increasing Awareness Regarding Blood Disorders to Propel Market Growth

The increasing awareness regarding the causes of blood disorders among the population can enhance the demand for acquired orphan blood diseases therapeutics. The prevalence of the disorder is increasing rapidly among the geriatric population, thereby driving the sales of the product. Further, governments are undertaking several initiatives to increase awareness among the population regarding several blood disorders. The stringent lifestyles of people can increase the prevalence of such blood disorders, which, in turn, necessitates the adoption of advanced orphan blood diseases therapeutics procedures, drugs, and other solutions. Therefore, these factors can drive the acquired orphan blood diseases therapeutics market growth.

However, strict government regulations on blood treatment procedures can hamper market growth.

Have Any Query? Ask Our Experts

Regional Insights

Heavy Investment on Research and Development Activities to Foster Market Growth in North America

North America is expected to lead in terms of the acquired orphan blood disease therapeutics market share due to heavy investments in research and development of better treatment procedures in the U.S. As per Statistica, approximately 13,000 patients suffer from von willebrand syndrome and about 18,000 patients have hemophilia. In addition, the prevalence of several blood disorders can boost the market growth.

In Europe, the rising cases of blood disorders among the population are expected to boost the demand for acquired orphan blood diseases therapeutics. Hence, this factor can propel market growth.

In Asia Pacific and Latin America, acquired orphan blood diseases therapeutics' increasing awareness can stoke market growth.

Competitive Landscape

Prominent Companies Announce FDA Approved Treatment Procedures to Enhance Brand Image

Prominent players operating in the market are announcingthe launch of advanced FDA-approved treatment procedures to improve their brand image. For example, the U.S. FDA approved ADDMEDICA's Orphan Drug Siklos in March 2018. Simultaneously, its sole hydroxyurea-based sickle cell anemia treatment was also approved by the U.S. FDA. This approval enabled the company to enhance its brand image globally. Additionally, significant investments in research and development procedures would lead to the emergence of better acquired orphan blood diseases therapeutics procedure. This strategy can helpcompanies to develop better treatment procedures and improve their market positions.

Industry Development

February 2019: Cablivi (caplacizumab-yhdp) injection received the U.S. FDA approval alongside immunosuppressive therapy and plasma exchange to cure thrombotic thrombocytopenic purpura (aTTP).
List of Key Players Profiled in the Acquired Orphan Blood Diseases Therapeutics Market Report

Amgen Inc.
Shire plc
Alexion Pharmaceuticals
Celgene Corporation
Rigel Pharmaceuticals, Inc.
Otsuka Pharmaceutical Pvt. Ltd.
Novo Nordisk Inc.
About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com
LinkedIn: https://www.linkedin.com/company/fortune-business-insights
Facebook: https://www.facebook.com/FortuneBusinessInsightsPvtLtd
Twitter: https://twitter.com/FBInsightPvtLtd

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acquired Orphan Blood Diseases Therapeutics Market to Boom; Increasing Prevalence of Blood Disorders to Bolster Industry Growth: Fortune Business Insights™ here

News-ID: 2372790 • Views: 204

More Releases from Fortune Business Insights

Genomic Market to rising at 18.7% CAGR by Top Players | Illumina, Inc., Thermo F …
Genomics Market Size | 2021 Covid-19 Impact On Healthcare Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast To 2028 is latest study published by Fortune Business Insights. The Global Genomics market expected to rise at notable CAGR and reach remarkable valuations by 2028. Genomics Industry is segmented By Type (Products, Services), Technology (Polymerase Chain Reaction, Next-generation Sequencing, Microarray, Sanger Sequencing),
U.S. Biosimilars Market Set For Rapid Growth Forecast 2020-2026| Key Players: F. …
U.S. Biosimilars Market | 2021 Size, Growth, Share, Cap, Regional Analysis With Global Industry Forecast To 2027. The “U.S. Biosimilars Market” will gain momentum from the increasing government support to adopt biosimilars in the healthcare sectors. According to a report by Fortune Business Insights, titled, “Biosimilars: U.S. Market Analysis, Insights and Forecast, 2019-2026,” The U.S. Biosimilars Market is projected to reach US$ 17,696.0 Mn by 2026. The report provides valuable
Pulse Oximeters Market by Key Players are Omron Healthcare, Inc., Philips Benelu …
Pulse Oximeters Market | 2021 Size, Growth, Share, Cap, Regional Analysis With Global Industry Forecast To 2027. The Global Pulse Oximeters Market is likely to grow in the coming years due to increasing usage clearances from the Food and Drug Administration (FDA). According to a report published by Fortune Business Insights, titled “Pulse Oximeters: Global Market Analysis, Insights and Forecast, 2018-2025,” the market is likely to reach US$ 2,657.6 Mn
Orthopedic Joint Replacement Market by Top International Players | Integra LifeS …
Orthopedic Joint Replacement Market | 2021 Size, Growth, Share, Cap, Regional Analysis With Global Industry Forecast To 2027. The global orthopedic joint replacement market size is poised to reach USD 26,967.9 million by 2026, exhibiting a CAGR of 5.1% during the forecast period. Combined rise in the incidence of osteoarthritis and geriatric population in the world will be the key force behind the growth of this market. Osteoarthritis is a lifelong

All 5 Releases


More Releases for Acquired

SOS acquired by PracticeEvolve
Solicitors Own Software (SOS) have announced the sale of the business to PracticeEvolve Group to continue to provide the market with progressive technology, supported by strong service and support. Operating since 1987, SOS have delivered practice and case management software and services to law firms across the UK. With over 17,000 users and a solid client base, Graham Colbourne, Managing Director, says the sale will ensure the market is provided
Global Acquired Aplastic Anemia Market Insights, Forecast
Acquired aplastic anemia is a rare, serious blood disorder, due to failure of the bone marrow failure to produce blood cells. Bone marrow is the spongy substance found in the center of the bones of the body, in adults mainly the spine, pelvis, and large bones of the legs. The global Acquired Aplastic Anemia market is valued at xx million US$ in 2018 and will reach xx million US$ by
Hospital Acquired Disease Testing - Evolving Market Trends
Global Hospital Acquired Disease Testing Market Insights  The rising incidence of hospital acquired infections (HAIs) has emerged as a major concern for governments, particularly across developing and underdeveloped countries. In first world countries such as the U.S., various regulations are in place for penalizing hospitals exhibiting a high incidence of HAIs. Such regulations augur well for the hospital acquired disease testing market in developed countries. In contrast, the absence of proper
CAROLINA UNDERGROUND SOLUTIONS ACQUIRED
Entrepreneur and Greenville Businessman, Braddock Cunningham, Acquires Carolina Underground Solutions Greenville, SC (May 30, 2017) – [CAROLINA UNDERGROUND SOLUTIONS] CUS, a leading underground telecommunications cabling and conduit contractor, today announced that they have been acquired by Braddock Cunningham, former CEO of Network Controls and Electric, where he grew his company to a South Carolina top 25 fastest growing company 4 times between 2008 and 2013. Cunningham who holds a
Noliac acquired by CTS Corporation
As of May 15th 2017, Noliac A/S has been acquired by CTS Corporation. Below is CTS' press release in this regard. CTS Acquires European Piezoelectric Sensor & Component Manufacturer Lisle, Ill. – CTS Corporation (NYSE: CTS) has announced the acquisition of Noliac A/S; a designer and manufacturer of tape cast and bulk piezoelectric components, sensors and transducers. Headquartered in Denmark with manufacturing facilities in Denmark and the Czech Republic, Noliac serves OEMs
Systech Illinois acquired by Union Park Capital
We are pleased to announce that Industrial Physics, Inc., a Boston-based test and measurement manufacturer and portfolio company of Union Park Capital have acquired Systech Illinois. Systech Illinois' application and technology expertise provides efficient gas analysis solutions in many industry sectors worldwide will be joined with TM Electronics in the Industrial Technology Group, as an independent operating entity under Industrial Physics. By combining resources the new formation will bring